A unique case of very low-dose subcutaneous ketamine use: Maintenance option of ketamine for treatment-resistant depression.

Adem T CanDaniel F HermensJim Lagopoulos

Published in: Clinical case reports (2022)

Numerous studies have demonstrated that low-dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment-resistant depression. The following case report describes the use of a very low-dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment-resistant depression using a retrospective chart review.

Keyphrases

low dose
high dose
case report
pain management
depressive symptoms
sleep quality
early onset
chronic pain
drug induced